HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction.

AbstractOBJECTIVES:
This study explored temporal trends in the use of aldosterone antagonist therapy among eligible patients with post-acute myocardial infarction (AMI) and reduced ejection fraction and characteristics associated with use in clinical practice.
BACKGROUND:
Current guidelines recommend initiation of aldosterone antagonist therapy post-AMI for patients with an ejection fraction ≤40% and heart failure or diabetes before hospital discharge, in the absence of contraindications.
METHODS:
Data from the American Heart Association's Get with the Guidelines-Coronary Artery Disease national database were analyzed for 81,570 post-AMI patients from 219 hospitals between 2006 and 2009, of whom 11,255 (13.8%) were eligible for aldosterone antagonist therapy.
RESULTS:
Among eligible patients, 1,023 (9.1%) were prescribed an aldosterone antagonist at discharge. Aldosterone antagonist use varied from 0% to 40% among hospitals. Patient and hospital characteristics independently associated with prescription of aldosterone antagonists were a history of diabetes, heart failure, coronary revascularization, and larger hospital size. Those with a history of kidney dysfunction, tobacco abuse, and higher ejection fraction were less likely to be prescribed an aldosterone antagonist. From 2006 to 2009, the use of aldosterone antagonists increased from 6.0% to 13.4% (p < 0.001).
CONCLUSIONS:
Although rates of aldosterone antagonist use are increasing slightly over time, the vast majority of AMI patients eligible for treatment fail to receive it at hospital discharge. The reason for this discrepancy between guideline-based therapy and actual prescribing patterns is unclear and should be further studied.
AuthorsAndrew N Rassi, Matthew A Cavender, Gregg C Fonarow, Christopher P Cannon, Adrian F Hernandez, Eric D Peterson, W Frank Peacock, Warren K Laskey, Sylvia E Rosas, Xin Zhao, Lee H Schwamm, Deepak L Bhatt
JournalJournal of the American College of Cardiology (J Am Coll Cardiol) Vol. 61 Issue 1 Pg. 35-40 (Jan 08 2013) ISSN: 1558-3597 [Electronic] United States
PMID23137936 (Publication Type: Journal Article)
CopyrightCopyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Mineralocorticoid Receptor Antagonists
Topics
  • Aged
  • Diabetes Mellitus (epidemiology)
  • Drug Prescriptions (statistics & numerical data)
  • Drug Utilization (statistics & numerical data, trends)
  • Female
  • Guideline Adherence (statistics & numerical data)
  • Heart Failure (epidemiology)
  • Hospital Bed Capacity
  • Humans
  • Kidney Diseases (epidemiology)
  • Male
  • Mineralocorticoid Receptor Antagonists (therapeutic use)
  • Multivariate Analysis
  • Myocardial Infarction (drug therapy, epidemiology)
  • Myocardial Revascularization
  • Patient Discharge
  • Practice Guidelines as Topic
  • Registries
  • Smoking (epidemiology)
  • Stroke Volume
  • United States (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: